Target intelligence / Profile preview

Small nucleolar RNA SNORA25 (SNORA25)

Target: SNORA25
Molecular classification: Small nucleolar RNA (snoRNA), non-coding RNA, H/ACA-box snoRNA family

Overview

Small nucleolar RNA SNORA25 guides site-specific pseudouridylation of rRNA, helping to modify nucleotides in ribosomal RNA through a conserved mechanism. It is a member of the H/ACA-box snoRNAs—a class of small non-coding RNAs located in the nucleolus, essential for proper maturation and function of ribosomes. SNORA25 does not code for protein, does not function as a receptor, enzyme, or transporter, and is not currently a focus of drug development.

Other names: LOC124900560ENSG00000201957SNORA25

Mechanism of action

Not applicable; SNORA25 does not act via known druggable mechanisms.

Biological functions

Site-specific pseudouridylation of ribosomal RNA (rRNA)

Disease associations

No established role in disease or specific associations with cancer, inflammation, neurodegenerative disease, cardiovascular disease, or infection. snoRNAs, in general, may be dysregulated in cancer and other diseases, but SNORA25-specific evidence is lacking in current research.

Safety considerations

None known; no therapeutic interventions or safety considerations related to SNORA25.

Interacting drugs

None reported

Biomarkers

None reported for SNORA25—no known use as a biomarker for patient selection or efficacy monitoring.

Beyond the preview

Go deeper on Small nucleolar RNA SNORA25 (SNORA25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nucleolar RNA SNORA25 (SNORA25).

Explore the full profile